SOMERSET, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the launch of its redesigned and enhanced Therapy Solution Suite, a cutting-edge, all-in-one web-based solution poised to transform therapy and rehabilitation practice management by offering an unparalleled combination of financial, operational, and clinical efficiency.
In the bustling world of therapy practice, managing multiple vendors, deciphering insurance complexities, and sacrificing personal time can take a toll. CareCloud’s Therapy Solution Suite steps in as a one-stop solution, seamlessly integrating six innovative components that streamline workflows, enhance patient engagement, and boost operational and financial efficiency.
Originally launched in March 2022, CareCloud's Therapy Solution Suite has been repackaged with new features and advancements to help fill a critical gap and meet the evolving needs of today's therapy practices. Key components of CareCloud's Therapy Solution Suite include:
"Drawing upon our extensive expertise in rehabilitation and therapy practices, which spans from small independent practices to an enterprise-level company with more than 2,500 clinicians, our Therapy Solution Suite is a meticulously designed, all-in-one solution that bridges the gaps left by other providers in the rehabilitation industry," stated Hadi Chaudhry, president and chief executive officer of CareCloud. "With our unparalleled hands-on familiarity with all six components in our offering, we are a trusted partner within the industry, and our solution has already been embraced and lauded by a larger player in this field.”
CareCloud’s end-to-end therapy management solution helps practices save time and resources, from referral to reimbursement. With their state-of-the-art technology and dedicated service professionals, practices can tailor workflows to perfectly align with specific needs. CareCloud’s solution is also designed to be accessible and cost-effective for practices of all sizes, and it seamlessly integrates with existing tech systems.
To learn more about CareCloud’s comprehensive suite of technology-enabled services and solutions, visit carecloud.com/solutions.
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
Company Contact:
Larry Steenvoorden
Chief Financial Officer
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Inquiries:
Kasey Cabello
Communications Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$1.25 |
Daily Change: | -0.01 -0.79 |
Daily Volume: | 645,400 |
Market Cap: | US$20.320M |
April 07, 2025 April 02, 2025 March 26, 2025 March 13, 2025 January 28, 2025 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load